share_log

Hannover Rück (OTC:HVRRF) Downgraded by UBS Group

kopsource ·  Jan 15, 2023 03:51

UBS Group downgraded shares of Hannover Rück (OTC:HVRRF – Get Rating) from a neutral rating to a sell rating in a report released on Thursday, The Fly reports.

Separately, Barclays increased their target price on shares of Hannover Rück from €133.70 ($143.76) to €149.50 ($160.75) and gave the company an underweight rating in a research report on Tuesday, November 22nd. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of Hold and an average target price of $175.83.

Get Hannover Rück alerts:

Hannover Rück Price Performance

Hannover Rück stock opened at $189.76 on Thursday. The business has a 50 day moving average of $170.21 and a 200-day moving average of $152.30. Hannover Rück has a 1 year low of $138.40 and a 1 year high of $203.15.

About Hannover Rück

(Get Rating)

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities.

See Also

  • Get a free copy of the StockNews.com research report on Hannover Rück (HVRRF)
  • MarketBeat: Week in Review 01/09-01/13
  • JPMorgan Chase Falls As Banks Brace For Recession
  • Why is the Bed Bath & Beyond Stock Price up 261%?
  • Roku Stock Price is Trending, Here's Why
  • Carvana Stock Rally, Here's What You Need to Know

Receive News & Ratings for Hannover Rück Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Rück and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment